Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Adults



Status:Recruiting
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - 65
Updated:3/6/2019
Start Date:November 26, 2018
End Date:March 2020
Contact:Gilead Clinical Study Information Center
Email:GileadClinicalTrials@gilead.com
Phone:1-833-445-3230 (GILEAD-0)

Use our guide to learn which trials are right for you!

A Phase 1b Randomized, Double-Blinded, Placebo Controlled, Multi-Cohort Study of the Safety, Pharmacokinetics, and Antiviral Activity of GS-6207 Administered Subcutaneously in HIV-1 Infected Subjects

The primary objective of this study is to evaluate the short-term antiviral activity of
GS-6207 compared to placebo in HIV-1 infected adults who are antiretroviral treatment naive
or are experienced but capsid inhibitor (CAI) naive.


Key Inclusion Criteria:

- Plasma HIV-1 RNA ≥ 10,000 copies/mL but ≤ 400,000 copies/mL and CD4+ cell count > 200
cells/mm^3

- Treatment naive or experienced but CAI and integrase strand transfer inhibitor (INSTI)
naïve, and have not received any antiretroviral therapy (ART) within 12 weeks of
screening

- Screening genotype report must show sensitivity to B/F/TAF to allow its initiation on
Day 10

- Screening genotype report must show sensitivity to at least one agent in either
non-nucleoside reverse transcriptase inhibitor (NNRTI) or protease inhibitor (PI)
class to allow its use as part of standard of care oral antiretroviral treatment in
the future

- Have adequate renal function (estimated glomerular filtration rate ≥ 70 mL/min)

- No clinically significant abnormalities in ECG at Screening

- Willing to initiate B/F/TAF on Day 10 after completion of all assessments

Key Exclusion Criteria:

- Pregnant or lactating

Note: Other protocol defined Inclusion/Exclusion criteria may apply.
We found this trial at
12
sites
5901 West Olympic Boulevard
Los Angeles, California 90036
1978
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Berkley, Michigan 48072
175
mi
from 43215
Berkley, MI
Click here to add this to my saved trials
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Fort Pierce, Florida 34982
882
mi
from 43215
Fort Pierce, FL
Click here to add this to my saved trials
937
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90069
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
1701 North Mills Avenue
Orlando, Florida 32803
(407)647-3960
Orlando Immunology Center Orlando Immunology Center , or simply (OIC) is a part of Infectious...
793
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Sacramento, California 95187
?
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
West Palm Beach, Florida 33401
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials